A biosimilar is a biologic drug that is highly similar, but not identical, to an already approved biologic drug, i.e. the reference...

An online advertising gold rush began from an unlikely source: meticulously mining the data beneath every click, scroll and interaction....

Sophisticated businesses face complex and fast-changing privacy laws. On the internet, many companies have chosen to address that...

This month, in Allergan USA, Inc. v. MSN Laboratories Private Ltd., the Federal Circuit added to the ongoing patent-family drama...

Copyright attorneys eagerly anticipated the U.S. Supreme Court's fair use opinion in Andy Warhol Foundation for the Visual Arts, Inc. v....

The district court in Salix Pharmaceuticals, Ltd. et al v. Norwich Pharmaceuticals, Inc., Civil Action No. 20-430-RGA (D. Del.) was asked...

Because judicial resources are limited, virtually all courts impose length limitations, such as word, page, or line limits, for briefing....

Although unusual, we have all heard of an attorney being disqualified from representing a client. We are also familiar with that...

Manufacturers of pharmaceuticals, biologics, and herbicides, as well as companies in virtually every industry, routinely make statements...

Based on recent headlines involving the expansion of the National Women's Soccer League, including its new $240 million media deals, the...

As we all know, injunctions are virtually impossible to obtain in federal patent litigation. However, the U.S. International Trade...

On October 17, 2023, the SEC issued a press release relating to certain defendants in a case brought against RenovaCare, Inc. and certain...